FDA Recalls USDA Recalls About

FDA Recalls

Food recalls
Drug recalls
Device recalls

USDA Recalls

All USDA recalls
Poultry recalls
Meat recalls
Egg recalls

About

About us
FDA guides
USDA guides
Data sources
Privacy policy

Data

OpenFDA API
USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

FDA Recalls
›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification

All Class I Class II Class III

Status

All Ongoing Completed Terminated

Date

All time Past 30 days Past 12 months

Showing 17041–17060 of 17,860 recalls

Class IITerminated

Methylcobalamin (Buffered) Injection,1 mg/mL, 30 mL vial, Stock# 11126, Preservative Free, Compounded by NuVision Pharmacy, Inc., Dallas, TX 75244

NuVision Pharmacy, Inc.

Lack of Assurance of Sterility; reports of adverse events after injection

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles ( NDC 60793-854-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened..

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles ( NDC 60793-851-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened.

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles ( NDC 60793-855-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened.

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened.

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened.

March 28, 2013 · DrugView details →

Class IICompleted

Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles ( NDC 60793-860-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Pfizer Inc.

Chemical contamination: emission of strong odor after package was opened.

March 28, 2013 · DrugView details →

Class IIITerminated

Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60

Legacy Pharmaceutical Packaging LLC

Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009

March 27, 2013 · DrugView details →

Class IITerminated

HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Vancomycin Ophthalmic PF, compounded by Pallimed Solutions Pharmacy, Wobrun, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Alprostadil IN NS Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Gentamicin Sulfate Irrigation, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Bacteriostatic Water for Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Acetylcysteine Ophthalmic Solution, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Testosterone Cypionate/Propionate Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Buprenorphine HCl Veterinary Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Nandrolone Decanoate Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Testosterone Cypionate Injection,compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Trimix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

Class IITerminated

Cyclosporine Ophthalmic, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

March 25, 2013 · DrugView details →

← PreviousPage 853 of 893Next →